Will a French vaccine against Covid-19 end up being authorized in Europe?
After Sanofi's setbacks and repeated delays, it's Valneva's turn to see its future darken.
The group based near Nantes announced on Monday that the European Commission was considering terminating the contract binding the two parties.
Clearly, the authority threatens to break the agreement which provides for up to 60 million doses delivered.
Subscribe to read more
Already subscribed?
To log in